BCL6 and cancer: The observation that the Bcl-6 inhibitor 79-6 enhanced endothelial sprouting in vitro and in vivo led to the pertinent question whether the anti-cancer compound might exert undesirable, tumor-promoting effects by boosting tumor angiogenesis.